In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.
What's the Take Home?
A 67-year-old woman is seen in the office a week after a long hospital admission for a variety of diabetes-related complications. She has had diabetes for 30 years, and her management has progressed from dietary changes to a variety of oral antidiabetes agents to, in recent years, injected insulin regimens.
Prediabetes is recognized as a serious health condition in the United States. In your opinion, should metformin be prescribed to patients with prediabetes to prevent progression to diabetes mellitus?
In this “Test Your Knowledge” series, Edward Shahady, MD, asks you to advise a patient about his blood glucose level and use of finger sticks.